Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Phase 1/2a Study of DTA-H19 in Advanced Stage Ovarian Cancer

This study has been completed.
Information provided by (Responsible Party):
BioCancell Ltd. Identifier:
First received: January 18, 2009
Last updated: November 12, 2012
Last verified: November 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2012
  Primary Completion Date: July 2012 (Final data collection date for primary outcome measure)